This page collects the key figures and concepts from this lesson. Use it as a study reference; HSCI 230, 341, and 410 will assume familiarity with this material.

Key figures introduced in this lesson

A consolidated course glossary will be published on the HSCI 130 index page.

Introduction and Overview

Nutritional science begins with diseases caused by what people didn't eat. For centuries, sailors on long voyages developed scurvy. Populations dependent on polished white rice developed beriberi. Populations dependent on corn developed pellagra. Children dependent on inadequate milk developed rickets. Each of these diseases was eventually shown to be caused by deficiency of a specific micronutrient. The investigation that established each link constitutes a founding case of nutritional epidemiology, and the public health interventions that followed — fortification programs that essentially eliminated these diseases in industrialized countries — are among the most cost-effective public health interventions ever devised. The work spanned roughly two centuries and involved everything from shipboard experiments to deliberate self-infection.

James Lind and the first controlled trial

In May 1747, aboard the British naval ship HMS Salisbury, a Scottish surgeon named James Lind (1716–1794) conducted what is widely regarded as the first controlled clinical trial in medical history. Scurvy was a devastating problem for the Royal Navy, killing more sailors on long voyages than enemy action. The cause was unknown. Lind hypothesized that the disease was related to diet and designed a comparative study.

He took twelve sailors with similar cases of scurvy and divided them into six pairs, each receiving a different treatment: cider, elixir of vitriol (sulfuric acid in alcohol), vinegar, sea water, oranges and lemons, or a paste of garlic, mustard, and horseradish. All other conditions — diet, bedding, ward — were held as constant as Lind could manage. After six days, the pair receiving citrus fruits had recovered enough to nurse the other patients. None of the other pairs improved.

Lind's experiment was not a randomized trial in the modern sense — he didn't randomize, didn't blind, and his sample was tiny — but it was a controlled comparison with a clear endpoint and a striking result. Lind published the findings in his 1753 Treatise of the Scurvy, but the Royal Navy did not adopt citrus rations as standard practice until 1795, more than four decades later. The delay reflects everything that public health has subsequently learned about how slowly evidence translates into practice when entrenched interests, supply-chain difficulties, and institutional inertia stand in the way. Once citrus rations were finally implemented, scurvy was essentially eliminated as a problem for the Royal Navy within a decade.

What Lind did not know — and could not have known — was that the active agent in citrus was vitamin C (ascorbic acid), an essential micronutrient for collagen synthesis. Vitamin C would not be isolated for another 180 years. The lesson is general: it is possible to identify effective interventions long before the underlying mechanism is understood, provided observation and comparison are disciplined.

Joseph Goldberger and pellagra

A century and a half after Lind, an American epidemiologist named Joseph Goldberger (1874–1929) conducted one of the most consequential — and most ethically unusual — series of investigations in nutritional epidemiology. Pellagra was an epidemic disease in the early-20th-century American South, particularly among poor white sharecroppers and African Americans. By the 1910s, pellagra was killing thousands of Americans each year, with characteristic symptoms of dermatitis, diarrhea, dementia, and (often) death.

The dominant medical opinion held that pellagra was infectious. Goldberger, a U.S. Public Health Service physician, was unconvinced. He observed that pellagra clustered in institutions (asylums, orphanages, prison farms) where the diet was monotonously corn-based, while the staff in those same institutions — eating different food — were not affected. He hypothesized that pellagra was a nutritional deficiency disease.

His investigations between 1914 and 1929 included a series of dramatic interventions. In an orphanage in Jackson, Mississippi, where pellagra was endemic, Goldberger and colleagues introduced eggs, milk, and meat into the diet. Pellagra disappeared within weeks. In a Mississippi prison farm, Goldberger persuaded the warden to feed selected prisoners a monotonous corn-based diet (offering the prisoners pardons in exchange); the prisoners developed pellagra on schedule, while controls did not. And — most strikingly — Goldberger and his collaborators (including his wife, Mary, and his colleagues at the U.S. Public Health Service) conducted what they called 'filth parties': injecting themselves with blood from pellagra patients, swallowing scrapings from pellagra-affected skin, and otherwise demonstrating that pellagra was not contagious. None of them developed pellagra.

Goldberger had identified pellagra as a deficiency disease but did not live to see the specific deficiency identified. Niacin (vitamin B3) was isolated as the missing nutrient by Conrad Elvehjem in 1937, eight years after Goldberger's death. Pellagra was essentially eliminated in the United States by mandatory niacin fortification of flour in 1938. Goldberger's investigations are now taught both as a founding case of nutritional epidemiology and as a case study in the ethics of research with vulnerable populations — the orphans and prisoners he worked with did not give informed consent in any modern sense, even though they appeared to benefit from his interventions.

The vitamin discoveries and fortification programs

Between roughly 1910 and 1950, nearly every major vitamin was isolated, structurally characterized, synthesized, and shown to be the missing component in a specific deficiency disease. Casimir Funk coined the term 'vitamin' (originally 'vitamine,' for 'vital amine') in 1912. Thiamine (B1) was isolated by Robert Williams in 1926 (preventing beriberi). Riboflavin (B2) was isolated in 1933. Vitamin C was isolated by Albert Szent-Györgyi in 1932 and synthesized in 1933. Vitamin D was identified in the 1920s and 1930s as the missing factor in rickets. Vitamin A was synthesized in 1937. Folic acid was characterized in 1941. Each isolation was a significant scientific achievement; collectively they constituted one of the largest improvements in human welfare in the 20th century.

The public health translation was through food fortification: adding essential micronutrients to widely-consumed staple foods. Iodization of salt began in Switzerland in 1924 and eliminated endemic goitre in regions where it had been a major problem for centuries. Vitamin D fortification of milk became widespread in the 1930s and 1940s (Canada made it mandatory in 1965), essentially eliminating rickets as a childhood disease in cold-climate countries. Niacin fortification of flour (1938) eliminated pellagra. Iron fortification of wheat and grain products (varies by country and decade) addressed iron-deficiency anemia. Folic acid fortification of flour, mandatory in Canada from 1998 and the United States from 1998, has reduced neural tube defects by roughly 50% in newborns.

Food fortification is one of the most cost-effective public health interventions ever devised. The marginal cost of adding micronutrients to industrially-produced staple foods is essentially zero. The interventions reach populations that voluntary supplementation cannot. They operate continuously without requiring individual behavior change. They produce population-wide benefits that compound over generations. They are, in this sense, a 21st-century descendant of the sanitary revolution: large-scale, infrastructure-based, structurally implemented interventions that work without requiring individual action.

Fortification has also raised ethical questions. Mandatory fortification modifies the food supply of every citizen without individual consent. The bar for mandating it should be high: clear benefit, negligible individual harm, no realistic alternative for reaching the affected population, and policy implementation through transparent democratic processes. Most fortification programs meet this bar. Some proposed expansions (e.g., calcium fortification, vitamin B12 fortification) are still under discussion and the case for each must be made specifically.

Why deficiency diseases still matter

Deficiency diseases have become rare in industrialized countries, but they are not extinct globally and are not even extinct domestically. Vitamin D deficiency is widespread — particularly in northern latitudes where winter sun exposure is inadequate for endogenous synthesis. Iron-deficiency anemia affects approximately 25% of women of reproductive age globally. Iodine deficiency affects approximately 1.9 billion people, mostly in developing countries. Vitamin A deficiency causes ~250,000-500,000 cases of childhood blindness per year globally. Folic acid coverage in countries without mandatory fortification produces preventable neural tube defects.

Even in Canada, specific subpopulations remain at risk. Children in food-insecure households have higher rates of multiple micronutrient deficiencies. Indigenous children in some communities have rates of vitamin D deficiency well above national averages. Pregnant women in some immigrant communities have higher rates of folate deficiency at conception. Older adults in institutional care frequently have inadequate vitamin D intake. Each of these subpopulations represents a sanitary-revolution-style problem — collective, structural, amenable to fortification — that is incompletely addressed.

And — importantly — the deficiency-disease framework has limited applicability to most modern nutritional problems. Obesity, cardiovascular disease, type 2 diabetes, and most contemporary chronic diseases are not deficiency diseases in any simple sense. They involve patterns of overconsumption (calories, processed foods, ultra-processed foods, sugars), inadequate consumption (whole grains, vegetables, fiber), and structural mismatches between food environments and human metabolism. The methodological tools of deficiency-disease nutrition do not always translate. We turn next to the harder problems — including the diet-related risks that together account for an estimated 11 million deaths globally each year (Afshin et al., 2019).

Introduction and Overview

Within a single century, the dominant nutritional public health problem in most countries shifted from too few calories to too many. The transition is incomplete — under- and over-nutrition often coexist in the same country, even the same family — but it has reshaped what nutrition science studies. The 20th-century shift was unprecedented in human history. For approximately 95% of the existence of Homo sapiens, periodic hunger and chronic food insecurity were the norm. For approximately the last 70 years, in approximately the half of the world's population that lives in industrialized countries, food has been continuously abundant, energy-dense, heavily processed, and aggressively marketed. The metabolic consequences are still being characterized. The political consequences are being fought over in real time.

The Seven Countries Study and the diet-heart hypothesis

Ancel Keys (1904–2004), a physiologist at the University of Minnesota, was one of the most influential and most controversial figures in 20th-century nutrition. He had become interested in dietary fat after observing during World War II — while developing the K-ration for American soldiers — that diet appeared to affect cardiovascular health. In the early 1950s, he proposed the 'diet-heart hypothesis': that saturated fat intake, mediated through serum cholesterol, caused atherosclerotic cardiovascular disease.

To test this hypothesis at the population level, Keys launched the Seven Countries Study in 1958. The study recruited middle-aged men from 16 cohorts in seven countries (the United States, Finland, Italy, Yugoslavia, Greece, the Netherlands, and Japan). Diet was characterized in detail at the population level; cardiovascular events were tracked prospectively. The findings, published initially in 1970 and elaborated over subsequent decades, showed strong associations between population-level saturated fat intake, serum cholesterol, and coronary heart disease mortality. Finland (high saturated fat intake) had high cardiovascular mortality; Greece and Japan (lower saturated fat, with the Mediterranean and Japanese diets respectively) had low cardiovascular mortality.

The Seven Countries Study is now contested in important ways. Country selection has been criticized as non-random and potentially confirmation-biased — there were 22 countries with relevant data; Keys selected seven. Other dietary factors (sugar, refined carbohydrates, ultra-processed food) were not adequately controlled or characterized. The mechanistic story — that saturated fat raises LDL cholesterol, which causes atherosclerosis — has been substantially refined; the relationship between dietary fat, serum cholesterol, and clinical outcomes is more complex than Keys's original model suggested, and the effect sizes of saturated fat replacement on cardiovascular mortality are smaller than the original framework implied.

Despite these qualifications, the Seven Countries Study remains foundational. The basic claim — that population-level dietary patterns affect cardiovascular disease — has been confirmed by every subsequent cohort and trial. The specific operationalization (saturated fat as the central variable) has been substantially modified but not abandoned. The Mediterranean diet pattern that Keys identified as protective has been validated in the PREDIMED trial (randomized intervention showing cardiovascular benefit; Estruch et al., 2018) and remains the most evidence-based dietary pattern for chronic disease prevention. The lesson is that founding studies can be both partly wrong and centrally right — and that nutritional science requires patient incremental work over decades, not single decisive studies.

The obesity epidemic emerges

Through most of the 20th century, obesity was an individual clinical curiosity rather than a population health concern. The transition began in the late 1970s and accelerated through the 1980s. Adult obesity prevalence in the United States, measured directly through NHANES (which uses physical measurement rather than self-report, avoiding self-report bias), tripled between 1975 and 2015 — from approximately 12% to approximately 40% (NCD Risk Factor Collaboration, 2017). Canadian rates, measured directly through the Canadian Health Measures Survey, are lower but follow a similar trajectory: from approximately 8% in 1985 to approximately 27% in 2019. Childhood obesity prevalence has roughly tripled over the same period.

The proximate causes are well-characterized: caloric surplus driven by abundant, inexpensive, energy-dense food; declining physical activity at work, in transportation, and in leisure; pervasive marketing of ultra-processed foods; changes in food preparation (more eating-out, more pre-prepared foods); changes in eating patterns (more snacking, larger portion sizes); and possibly environmental factors (endocrine-disrupting chemicals, sleep disruption, microbiome alterations) that are still being characterized. None of these proximate causes is in serious dispute.

The structural causes are where the political fight is. The food environment — the availability, pricing, marketing, and placement of food retailers, food products, and meals — has been transformed by post-1970 industrial food system changes. Agricultural subsidies in the US (much less in Canada) have produced extraordinarily cheap calories from corn (high-fructose corn syrup) and oilseeds (industrial seed oils). Marketing to children, particularly through television and now through digital platforms, has shaped childhood preferences. Portion sizes have grown — a 1985 hamburger contained roughly 330 calories; a 2020 fast-food hamburger plus fries plus drink commonly contains 1,000-1,500 calories. The built environment has shifted toward car-dependent suburban development that discourages active transport. Each of these structural factors contributes; addressing any one is politically difficult; addressing all of them simultaneously has not been seriously attempted in any country.

The health consequences are substantial. Obesity is associated with elevated risk of type 2 diabetes, cardiovascular disease, several cancers (breast, colorectal, endometrial, pancreatic, others), musculoskeletal disorders, sleep apnea, depression, and a range of other conditions. The recent emergence of GLP-1 receptor agonists (Ozempic, Wegovy, and analogous drugs) has produced unprecedented pharmacological weight loss in clinical trials, but the medications are expensive, require lifelong use, and don't address the underlying environmental drivers. Whether GLP-1 drugs become a partial population-level solution or a luxury intervention for those who can afford them is one of the most consequential ongoing stories in public health.

The nutrition transition

Barry Popkin (University of North Carolina at Chapel Hill) developed the most influential framework for understanding population-level dietary change. The nutrition transition, articulated by Popkin in a series of papers from the 1990s onward, describes a sequence of patterns: from hunger and infectious disease to receding famine; from receding famine to nutrition-related noncommunicable disease (the current pattern in most middle- and high-income countries); and (Popkin's normative hope) toward behavioral and policy change that addresses the noncommunicable disease burden.

The framework is useful because it captures the global pattern. Countries that achieved food security in the mid-20th century — most of Europe, North America, Japan, Australia, New Zealand — entered the noncommunicable disease phase first. China, India, and many other middle-income countries are transitioning rapidly through the mid-2020s. Several African countries are now seeing the early stages: obesity and diabetes are rising even as undernutrition persists, producing the 'double burden' pattern where overnutrition and undernutrition coexist within the same population, sometimes the same household.

One of the most striking observations from the nutrition transition literature is how quickly it operates. Mexico, for instance, transitioned from a country with substantial undernutrition in the 1970s to a country with one of the world's highest rates of childhood and adult obesity by the 2010s — a transition spanning a single generation. The Mexican government's response, including the 2014 sugar-sweetened beverage tax (an excise tax of approximately 1 peso per liter on sugary drinks), was one of the most ambitious structural public health interventions of the past decade. Initial evaluations suggest the tax produced measurable reductions in sugary drink consumption and modest contributions to obesity prevention (Colchero, Rivera-Dommarco, Popkin, & Ng, 2017). Similar taxes have since been implemented in the UK (2018), South Africa, several US cities, and elsewhere.

The Mexican SSB tax is one of the cleaner examples of a structural nutrition intervention working at scale. Most other structural interventions — front-of-package warning labels (Chile's black-octagon warning system, implemented 2016, is a notable example), restrictions on marketing to children, restrictions on food retailers near schools, school meal program reforms — have produced more modest or harder-to-isolate effects. The political difficulty is consistent: food industry opposition is well-funded and politically effective, and individual-level interventions (diet advice, nutrition counseling) are politically cheaper but less effective at population level.

The sugar story

In 2016, a paper published in JAMA Internal Medicine by Cristin Kearns, Laura Schmidt, and Stanton Glantz at the University of California, San Francisco, revealed internal industry documents from the Sugar Research Foundation (Kearns, Schmidt, & Glantz, 2016). The documents showed that in the 1960s, the Sugar Research Foundation had funded a 1967 New England Journal of Medicine review article that minimized sugar's role in cardiovascular disease and emphasized saturated fat as the primary dietary villain. The funding source was not disclosed in the review. The review's authors received what would today be substantial honoraria (about $50,000 in 2016 dollars) from the sugar industry while writing it.

The story matters because it reveals how nutrition science was distorted at a foundational moment. The early dominance of the diet-heart hypothesis — with saturated fat as the primary target and sugar as comparatively neglected — was not just the natural development of the science. Industry funding had a finger on the scale. Subsequent research has confirmed that added sugars, particularly in liquid form, contribute substantially to cardiovascular and metabolic disease risk. The 1960s misdirection cost decades of public health attention.

The reaction has been substantial. Modern nutrition science treats industry-funded research with skepticism analogous to that previously reserved for tobacco-funded research. Journals require detailed disclosure of conflicts of interest. The 2020-2025 cycle of US Dietary Guidelines explicitly excluded industry-funded research from certain types of reviews. The 2015 Canadian Dietary Guidelines revision substantially reduced industry input into the process. None of these reforms are complete; industry funding remains substantial in nutrition science, and untangling its influence is ongoing work. But the sugar story has produced durable institutional change.

The broader lesson is general. Science funded by industries with financial stakes in particular outcomes is, on average, more favorable to those outcomes than independent science. This is not a claim about the moral character of individual researchers but about the structural pull of funding on which questions get asked, which outcomes get measured, and which results get published. The corrective is not the elimination of industry funding (often impossible) but transparent disclosure, structural protection of research independence, and skeptical reading by trained scientists and informed citizens (Mozaffarian, 2016).

Introduction and Overview

The idea that lack of physical activity is itself a health risk is younger than most students realize. Before about 1950, sedentary work was considered an advantage — a sign of having moved up the social ladder, away from the physical labor of agricultural and industrial work. The science that turned this around began with a London transit study by a public health physician with a particular interest in social-class effects on health. From that founding observation, physical activity epidemiology has grown into one of the most active subfields of public health, with consistent findings about the health benefits of activity and persistent difficulty translating those findings into population-level behavior change.

Jerry Morris's London bus drivers (1953)

Jeremy ('Jerry') Morris (1910–2009) was a British public health physician with a particular interest in social-class gradients in disease. In the early 1950s, he was looking for a way to test whether physical activity itself — independent of social class, diet, and other factors — affected cardiovascular disease risk. The London Transport authority offered an ideal natural experiment.

The double-decker buses of London in the 1950s were staffed by two-person crews: a driver who sat at the wheel of the bus for an eight-hour shift, and a conductor who collected fares and managed passenger flow by climbing up and down the stairs of the double-decker many times per shift. The driver and the conductor were drawn from the same socioeconomic background, ate at the same canteens, lived in similar neighborhoods, and were subject to the same workplace conditions. They differed primarily in physical activity: the conductor climbed an estimated 600+ stairs per shift, while the driver was essentially stationary all day.

Morris and colleagues compared coronary heart disease rates between drivers and conductors. The results, published in The Lancet in November 1953 (Morris, Heady, Raffle, Roberts, & Parks, 1953), were striking. Drivers had approximately double the rate of coronary heart disease compared with conductors. Sudden cardiac death was particularly elevated among drivers. The pattern persisted after controlling for the factors known at the time to influence cardiovascular risk. Physical activity itself, Morris concluded, was protective.

The Morris study has methodological limitations that subsequent research has identified. The most important is healthy-worker selection: men who were already healthy enough for the physically demanding conductor job might have been at lower cardiovascular risk to start with, and men with early disease might have self-selected into the sedentary driver role. Morris was aware of this and noted that even within job categories, more-active workers had lower rates. The modern way to address the selection problem is randomized trials of exercise interventions (which have replicated the protective effect at smaller scale) and Mendelian randomization studies using genetic variants associated with physical activity. The Morris study is therefore best understood not as definitive but as the hypothesis-generating observation that motivated a 70-year research program. Morris himself continued working in physical activity epidemiology until his death at age 99 — having essentially proved his own hypothesis through personal example.

Exercise, physical activity, sedentary behavior

As physical activity epidemiology developed, it progressively expanded what it measured. Early studies focused on exercise — intentional physical activity for the purpose of fitness. Subsequent work expanded to physical activity more broadly, including occupational activity, active transport (walking and cycling), and household activity. Most recently, the field has identified sedentary behavior — prolonged sitting — as an independent risk factor, not just the absence of physical activity.

The distinctions matter. A person who exercises vigorously for 30 minutes per day but sits for 14 hours otherwise (the modern office worker) has a different risk profile from a person with the same exercise dose who walks and stands throughout the day. The 'active couch potato' phenomenon — meeting exercise guidelines but otherwise sedentary — has been characterized in multiple cohort studies as carrying elevated cardiovascular and metabolic risk even with adequate exercise. Conversely, light-intensity activity throughout the day (walking, standing, household activity) appears to confer health benefits not reducible to formal exercise.

The Canadian 24-Hour Movement Guidelines, released by the Canadian Society for Exercise Physiology in 2020 (Ross et al., 2020), reflect this evolution. The guidelines specify integrated targets for moderate-to-vigorous physical activity (150 minutes per week for adults), muscle strengthening activity (twice weekly), sleep duration (7-9 hours), and sedentary time (limited; specifically, limiting sitting to no more than 8 hours per day with no more than 3 hours of recreational screen time). The 24-hour framework is methodologically innovative — it treats the day as a fixed resource that has to be allocated among activity, sleep, and sedentary time, rather than treating each in isolation. The guidelines are increasingly influential internationally.

The 'sitting is the new smoking' framing popular in the 2010s overstates the comparison — smoking is substantially worse than sitting on a dose-response basis — but it captures something real. Prolonged sedentary time is an independent risk factor that the field largely missed until the 2000s. Standing desks, active workstations, and structural interventions to reduce sitting (sit-stand schedules in offices, walking meetings) are now mainstream workplace recommendations.

Exercise as medicine — and as social policy

The cumulative evidence on physical activity is now substantial enough that exercise is sometimes called 'the best buy in public health' (a phrase Morris coined late in his career). The dose-response is well-characterized: ~150 minutes/week of moderate-intensity activity (the WHO and Canadian recommendation) produces substantial cardiovascular, metabolic, mental health, and mortality benefits, with continuing returns up to much higher doses. The effect sizes are large: meeting the activity guideline is associated with roughly 30% reduction in all-cause mortality in observational studies, with appropriate adjustment for selection effects (Lee et al., 2012).

The intervention question is harder than the evidence question. Individual-level interventions — exercise prescriptions, behavioral counseling, gym memberships, fitness apps — have modest population-level effects. Most adults who join gyms in January don't remain active by March. Most exercise prescriptions are not filled. Most fitness apps are abandoned within months. The structural interventions that work — built environments that make active transport convenient, school physical education programs that reach all children, workplace policies that allow movement throughout the day — are politically harder to implement but produce larger and more durable effects.

The contemporary policy frontier is the built environment. Cities like Vancouver, Toronto, and Montreal have introduced bicycle infrastructure investments, walkable neighborhood policies, and transit-oriented development that, over decades, are shifting activity patterns. Some early evaluation suggests measurable population-level effects on physical activity from these changes, though attribution is methodologically difficult. The international comparison is striking: countries that designed for active transport (the Netherlands, Denmark, parts of Japan) have substantially higher population activity levels with no specific 'exercise program.'

From individual to structural

The arc of physical activity epidemiology mirrors broader patterns in public health. The field began with observations of individual exposures and outcomes (Morris's drivers vs. conductors). It developed into a robust evidence base that physical activity prevents chronic disease and premature death. It produced individual-level intervention guidelines and counseling protocols. It identified that those interventions had limited population-level impact. It is now moving — incompletely — toward structural interventions on the built environment, workplaces, schools, and transportation systems that shape activity at the population level.

The same arc applies to nutrition (individual dietary advice → fortification, taxes, marketing restrictions) and to tobacco (individual quit advice → taxation, advertising bans, smoke-free environments). In each case, the individual approach is politically cheaper and easier but less effective; the structural approach is politically more difficult but more effective at scale. The lesson is general and recurring. A modern public health practitioner working on physical activity should be familiar with individual-level intervention but oriented toward structural change as the primary lever.

Introduction and Overview

Sleep science as a recognizable field is younger than most of your professors. The two foundational discoveries — REM sleep (1953) and the molecular machinery of circadian rhythms (Nobel Prize 2017) — both happened in living memory. Sleep is now established as a fundamental physiological process with substantial health consequences when disrupted. But sleep is also the hardest of the three lifestyle factors to intervene on at the population level: it intersects with work scheduling, school start times, light pollution, social structure, and economic precarity in ways that no single public health agency owns. The science is solid; the policy infrastructure is barely existent. This section walks through how sleep became a science and where the field stands now.

REM sleep and the architecture of the night

For most of human history, sleep was treated as a uniform state of unconsciousness — passive, restorative, not particularly worth scientific investigation. The discovery that changed this happened in 1953, in the lab of Nathaniel Kleitman (1895–1999) at the University of Chicago. Kleitman, a Russian-American physiologist, had been studying sleep since the 1920s; he had even spent extended periods in caves to study circadian rhythms in the absence of external time cues. His graduate student Eugene Aserinsky (1921–1998), monitoring a sleeping subject's eye movements with an electrooculogram, observed that the eyes underwent periods of rapid coordinated movement followed by stillness — and that these periods correlated with vivid dreaming when the subject was awoken during them.

The Aserinsky-Kleitman paper, published in Science in September 1953 (Aserinsky & Kleitman, 1953), described rapid eye movement (REM) sleep as a distinct sleep state alternating with non-REM sleep across the night. The discovery launched the entire field of sleep medicine. Modern sleep architecture — REM/NREM cycles, slow-wave sleep, sleep stages — all descends from this work. Aserinsky, who completed his PhD on the topic, did not initially recognize the importance of his own discovery; he left the field for a decade before returning to it.

The functional significance of REM sleep is still debated. REM is associated with vivid dreaming, with memory consolidation (particularly emotional and procedural memory), with synaptic remodeling, and with regulation of mood and emotional processing. People deprived of REM sleep specifically (typically through medication-induced REM suppression) develop measurable cognitive and emotional disruption. The total REM deprivation rebound observed after sleep restriction — animals and humans recover lost REM disproportionately when subsequent sleep is allowed — suggests a homeostatic function that the body actively protects.

The Aserinsky-Kleitman discovery had enormous downstream consequences. Sleep medicine emerged as a clinical specialty in the 1960s and 1970s. Polysomnography (the multi-channel recording of sleep stages, eye movements, muscle tone, heart rate, and breathing) became standard clinical practice. Diagnostic categories — narcolepsy, sleep apnea, REM behavior disorder, restless legs syndrome — were established and validated. Most importantly for our purposes: sleep became a population health concern, not just a clinical curiosity. The science that made this possible started with a graduate student's observation of an eye movement.

Circadian biology and the molecular clock

The other foundational sleep discovery — for which the 2017 Nobel Prize in Physiology or Medicine was awarded to Jeffrey Hall, Michael Rosbash, and Michael Young — addressed how the body knows what time it is. The phenomenon of circadian rhythm — biological cycles of roughly 24 hours, persisting even in the absence of environmental cues — had been observed since antiquity. The molecular machinery underlying it was a mystery until the 1980s.

Working with the fruit fly Drosophila, Hall, Rosbash, and Young identified a network of genes — Period, Timeless, Clock, Cycle (and mammalian analogs BMAL1, PER, CRY) — that produce proteins on a roughly 24-hour cycle through transcription-translation feedback loops. The mechanism is conserved across essentially every multicellular organism. Each cell of your body has a molecular clock; tissue-level coordination is maintained by the suprachiasmatic nucleus of the hypothalamus, which receives input from retinal light-sensing pathways and synchronizes peripheral clocks.

The clinical implications of this work are enormous and still being processed. Sleep timing matters as well as sleep duration. The pre-sleep light environment (particularly blue-spectrum light from screens) affects melatonin secretion and sleep onset. Eating patterns interact with circadian biology in ways that affect metabolism (early eating, with the largest meal at midday, is consistently associated with better metabolic outcomes than late eating). Medications can have substantially different effects depending on the time of day they are administered (a field called chronopharmacology, now incorporating into oncology, cardiology, and other specialties). Shift work — discussed below — is a chronic circadian disruption with measurable health consequences.

The contemporary understanding is that human biology is fundamentally a 24-hour system. The post-Edison electric-lighting environment, which decouples activity from solar cycles, is in some ways more biologically disruptive than industrialized populations recognize. The contemporary public health response is mostly individual-level (sleep hygiene recommendations, blue-light filters, melatonin supplementation) and structurally minimal. Some early structural interventions — later school start times for adolescents, restrictions on shift work schedules — are being tested but remain politically marginal.

Shift work as a probable carcinogen

In October 2007, the International Agency for Research on Cancer (IARC) — the WHO body that classifies environmental carcinogens — classified shift work that involves circadian disruption as a probable human carcinogen (Group 2A, the same category as red meat consumption and certain pesticides; Straif et al., 2007). The classification was based on accumulated evidence from cohort studies of nurses, flight attendants, and other shift workers showing elevated rates of breast cancer, and on substantial mechanistic evidence in animal models showing that circadian disruption affects tumor growth.

The IARC classification has had limited regulatory consequences. Much necessary work (healthcare, transport, manufacturing, emergency services) cannot be done during daylight hours only, and society broadly relies on 24-hour service availability. The response has focused on minimizing disruption rather than eliminating exposure: forward-rotating schedules (clockwise schedule progression, which is biologically less disruptive than counter-clockwise), scheduled napping during long shifts, restricting consecutive night shifts, ensuring adequate rest between shifts, and increasing recovery time after night-shift sequences. None of these substantially eliminate the underlying circadian disruption.

The shift-work issue illustrates a recurring tension in public health. The science is clear: shift work causes harm at the population level. The political and economic constraints are also clear: shift work is structurally necessary for many functions society depends on. The public health response has therefore been incremental and partial. Whether more aggressive intervention (substantial wage premiums for shift work, mandatory recovery periods, restrictions on consecutive night shifts) will eventually emerge depends on political conditions that are not currently in place.

Sleep in population health

Modern surveys consistently find that around one-third of adults sleep less than the recommended 7 hours per night (Hirshkowitz et al., 2015). Roughly 10-15% report chronic insufficient sleep. Sleep disorders, particularly obstructive sleep apnea, are heavily under-diagnosed; epidemiological estimates suggest 25-30% of adults have moderate or severe obstructive sleep apnea, of whom approximately 80% are undiagnosed. The 'sleep gap' — lower sleep quantity and quality in lower-socioeconomic-status populations — is now treated as a social determinant of health in its own right.

Sleep duration shows a U-shaped relationship with mortality and chronic disease — both too little (typically operationalized as <6 hours) and too much (>9 hours) sleep are associated with elevated risk (Cappuccio, D'Elia, Strazzullo, & Miller, 2010). The interpretation of the too-much side is contested: long sleep often reflects underlying illness (depression, sleep apnea, chronic illness recovery) rather than excess sleep causing harm directly. The too-little side has clearer causal interpretation, supported by experimental sleep-restriction studies showing measurable effects on metabolic, cardiovascular, immune, and cognitive function within days.

The contemporary policy frontier is structural intervention on sleep. School start times have received the most attention; the American Academy of Pediatrics recommended in 2014 that middle and high schools start no earlier than 8:30 a.m. to accommodate adolescent circadian biology, and several US states (California most prominently) have legislated later school start times since. Canadian provinces are debating analogous changes. Workplace policies on shift work, including limits on consecutive night shifts and mandatory recovery periods, are increasingly under discussion. Light pollution policies, building codes mandating sleep-supportive lighting environments, and restrictions on late-night digital marketing to children have been proposed but rarely implemented. The structural infrastructure for sleep policy remains underdeveloped compared with diet, activity, and tobacco.

Bringing It All Together

This lesson has walked you through the full arc of the topic across all four sections. As you complete this final assessment, draw on each section to consolidate what you have learned and to prepare for the lessons that build on it.

The list below distills the core ideas the rest of the course will keep coming back to. Read them as a checklist: if any feel unfamiliar, jump back into the relevant section before you take the assessment, since later lessons will assume each of them as common ground.

Data Spotlight

Forward Link

HSCI 410 returns to lifestyle factors as exposures in chronic disease epidemiology, with formal methods for handling self-reported diet, accelerometer data, and the confounding that lifestyle research is famously full of. HSCI 230 will cover the cohort and trial designs used to characterize lifestyle-disease relationships. HSCI 130 gives you the substantive grounding in what the major studies actually found.

Final Reflection

Comprehensive Knowledge Check

This 15-question assessment covers all four sections of Lesson 4. Aim for at least 12 of 15 correct. You may retry until you reach mastery.